Zenas BioPharma, Inc. ZBIO

Updated: 18 Jun 2026

NASDAQ | Biotech | Biopharmaceutical development of immunotherapies

No signal published yet

We already track Zenas BioPharma and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Zenas BioPharma free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biopharmaceutical development of immunotherapies
We're already tracking Zenas BioPharma, Inc. — here are the latest events we've registered

Recent News

  • In June 2026, Zenas announced positive Phase 3 results for obexelimab in the New England Journal of Medicine and submitted a Biologics License Application to the FDA. The company also presented its clinical pipeline at the H.C. Wainwright Neuro Perspectives Expert Summit in mid-June 2026.

What Firelda Watch includes for Zenas BioPharma, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Zenas BioPharma, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Recipharm
RECI B
NEUTRAL
Moderna, Inc.
MRNA
HOLD
AstraZeneca PLC
AZN
HOLD
Calliditas Therapeutics
CALT
NEUTRAL
Ionis Pharmaceuticals, Inc.
IONS
HOLD

Biotech

More companies in this sector

Want to follow Zenas BioPharma, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Zenas BioPharma free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Zenas BioPharma, Inc. ZBIO
Zenas BioPharma — follow and we'll monitor it
Follow Zenas BioPharma free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.